Certificate of Analysis Available
Independent lab report — identity, mass, and ≥99% purity. View the full COA library.
Tesamorelin/Ipamorelin
This research-grade blend combines Tesamorelin and Ipamorelin (13/3mg) in a synergistic formulation designed for in vitro and ex vivo growth hormone pathway investigations. The blend leverages complementary mechanisms of action—GHRH receptor agonism (Tesamorelin) and ghrelin receptor modulation (Ipamorelin)—to enable comprehensive studies of pulsatile growth hormone dynamics.
CAS #: Tesamorelin: 218949-48-5; Ipamorelin: 170851-70-4
Certificate of Analysis Available
Independent lab report — identity, mass, and ≥99% purity. View the full COA library.
Product Description
This research-grade blend combines Tesamorelin and Ipamorelin (13/3mg) in a synergistic formulation designed for in vitro and ex vivo growth hormone pathway investigations. The blend leverages complementary mechanisms of action—GHRH receptor agonism (Tesamorelin) and ghrelin receptor modulation (Ipamorelin)—to enable comprehensive studies of pulsatile growth hormone dynamics.
Specifications
| Strength | 13mg/3mg |
|---|

